Seromycin
REMEDYREPACK INC.
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
SEROMYCIN DESCRIPTION
CLINICAL PHARMACOLOGY
Microbiology
Susceptibility Tests
INDICATIONS & USAGE
SEROMYCIN CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
General
LABORATORY TESTS
DRUG INTERACTIONS
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
PREGNANCY
NURSING MOTHERS
PEDIATRIC USE
SEROMYCIN ADVERSE REACTIONS
OVERDOSAGE
Signs and Symptoms
Treatment
DOSAGE & ADMINISTRATION
HOW SUPPLIED
REFERENCES
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
Seromycin
CYCLOSERINE CAPSULE
Product Information
|
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:49349-018(NDC:0002-0604) |
|
Route of Administration
|
ORAL |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
|
Ingredient Name
|
Basis of Strength
|
Strength
|
|
CYCLOSERINE CYCLOSERINE |
|
250 mg
|
Product Characteristics
|
|
Color
|
Size
|
Imprint Code
|
Shape
|
|
gray |
20 mm |
LILLY;F04 |
CAPSULE |
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
NDC:49349-018-02 |
30 in 1 BLISTER PACK |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
ANDA |
ANDA060593 |
2011-08-02 |
|
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
